Product Details:
Packaging Size | 3*10 Tab |
Brand | VEENAT 400 |
Composition | Imatinib mesylate (400mg) |
Manufacturer | NATCO |
Treatment | Veenat 400 Tablet belongs to the class of medicines known as tyrosine kinase inhibitors. It is used |
Prescription/Non prescription | Prescription |
Form | Tablet |
Product Details:
Packaging Size | 10 Tab |
Brand | Armotraz |
Composition | Anastrozole (1mg) |
Manufacturer | Cipla |
Treatment | Armotraz Tablet is used alone or with other treatments, such as surgery or radiation, to treat early |
Prescription/Non prescription | Prescription |
Form | Tablet |
Product Details:
Packaging Size | 10*10 Tablets |
Brand | Cytotam 20 |
Composition | Tamoxifen (20mg) |
Manufacturer | Cipla |
Treatment | It is used in the treatment of breast cancer |
Prescription/Non prescription | Prescription |
Form | Tablet |
Product Details:
Brand | Cytotam 10 |
Composition | Tamoxifen (10mg) |
Manufacturer | Cipla |
Treatment | It is used in the treatment of breast cancer |
Prescription/Non prescription | Prescription |
Form | Tablet |
Product Details:
Packaging Size | 1 Vial of 16 ml |
Brand | Avastin |
Composition | Bevacizumab injection |
Manufacturer | Cipla |
Treatment | Anti Cancer Treatment |
Prescription/Non prescription | Prescription |
Product Details:
Packaging Size | 1*10 |
Brand | Capegaurd |
Composition | Capecitabine Tablet IP 500 mg |
Manufacturer | Cipla |
Treatment | Anti Cancer Treatment |
Prescription/Non prescription | Prescription |
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Product Details:
Manufacturer | Mylan |
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information:
Additional Information: